Showing 1 - 4 results of 4 for search 'B. Chyla', query time: 0.02s
Refine Results
-
1
P561: VIALE-T: A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF VENETOCLAX IN COMBINATION WITH AZACITIDINE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKE... by C. Craddock, U. Platzbecker, M. Heuser, V. Pullarkat, S. Chaudhury, D. Wu, S. Addo, B. Chyla, Q. Jiang, P. Lee, J. E. Wolff
Published 2022-06-01
Article -
2
S148: VENETOCLAX-OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 5-YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY by O. Al-Sawaf, C. Zhang, S. Robrecht, A. Kotak, N. Chang, A.-M. Fink, E. Tausch, C. Schneider, M. Ritgen, K.-A. Kreuzer, B. Chyla, B. Eichhorst, Y. Jiang, S. Stilgenbauer, M. Hallek, K. Fischer
Published 2022-06-01
Article -
3
S146: VENETOCLAX IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH 17P DELETION: 6-YEAR FOLLOW-UP AND GENOMIC ANALYSES IN A PIVOTAL PHASE 2 TRIAL by S. Stilgenbauer, E. Tausch, A. W. Roberts, M. S. Davids, B. Eichhorst, M. Hallek, P. Hillmen, C. Schneider, S. Böttcher, R. Popovic, M. T. Ghanim, M. Moran, W. J. Sinai, X. Wang, N. Mukherjee, B. Chyla, W. G. Wierda, J. F. Seymour
Published 2022-06-01
Article -
4
S143: TRANSCRIPTOMIC CHARACTERIZATION OF MRD RESPONSE AND NON-RESPONSE IN PATIENTS TREATED WITH FIXED-DURATION VENETOCLAX-OBINUTUZUMAB by O. Al-Sawaf, H. Y. Jin, C. Zhang, Y. Choi, S. Balasubramanian, S. Robrecht, A. Kotak, N. Chang, A.-M. Fink, E. Tausch, C. Schneider, M. Ritgen, K.-A. Kreuzer, B. Chyla, J. Paulson, B. Eichhorst, S. Stilgenbauer, Y. Jiang, M. Hallek, K. Fischer
Published 2022-06-01
Article